Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis
- 1 May 2007
- journal article
- other
- Published by Elsevier in Joint Bone Spine
- Vol. 74 (3) , 304-305
- https://doi.org/10.1016/j.jbspin.2006.11.005
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Blocking of Interleukin-17 during Reactivation of Experimental Arthritis Prevents Joint Inflammation and Bone Erosion by Decreasing RANKL and Interleukin-1The American Journal of Pathology, 2005
- Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitisJournal of Clinical Investigation, 2005
- Expression of interleukin-17B in mouse embryonic limb buds and regulation by BMP-7 and bFGFBiochemical and Biophysical Research Communications, 2005
- Osteoporosis and ankylosing spondylitisJoint Bone Spine, 2004
- IL-17 in rheumatoid arthritis: a new target for treatment or just another cytokine?Joint Bone Spine, 2004
- Biology of recently discovered cytokines: Interleukin-17 – a unique inflammatory cytokine with roles in bone biology and arthritisArthritis Research & Therapy, 2004
- Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing miceJournal of Clinical Investigation, 2003